HomeCompareMTSFF vs MRK

MTSFF vs MRK: Dividend Comparison 2026

MTSFF yields 2.24% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MTSFF wins by $74.69M in total portfolio value· pulled ahead in Year 2
10 years
MTSFF
MTSFF
● Live price
2.24%
Share price
$10.29
Annual div
$0.23
5Y div CAGR
98%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$74.75M
Annual income
$68,265,006.42
Full MTSFF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — MTSFF vs MRK

📍 MTSFF pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMTSFFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MTSFF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MTSFF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MTSFF
Annual income on $10K today (after 15% tax)
$189.99/yr
After 10yr DRIP, annual income (after tax)
$58,025,255.46/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, MTSFF beats the other by $58,016,658.74/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MTSFF + MRK for your $10,000?

MTSFF: 50%MRK: 50%
100% MRK50/50100% MTSFF
Portfolio after 10yr
$37.41M
Annual income
$34,137,560.10/yr
Blended yield
91.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MTSFF
No analyst data
Altman Z
1.0
Piotroski
5/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MTSFF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMTSFFMRK
Forward yield2.24%2.81%
Annual dividend / share$0.23$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR98%32.7%
Portfolio after 10y$74.75M$57.7K
Annual income after 10y$68,265,006.42$10,113.78
Total dividends collected$74.23M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MTSFF vs MRK ($10,000, DRIP)

YearMTSFF PortfolioMTSFF Income/yrMRK PortfolioMRK Income/yrGap
1$11,143$442.57$11,213$373.04$70.00MRK
2← crossover$12,835$912.52$12,667$512.06+$168.00MTSFF
3$15,679$1,945.09$14,439$708.14+$1.2KMTSFF
4$21,173$4,396.73$16,640$988.16+$4.5KMTSFF
5$33,642$10,987.08$19,432$1,394.07+$14.2KMTSFF
6$68,302$32,304.78$23,057$1,992.90+$45.2KMTSFF
7$194,449$121,366.24$27,889$2,894.79+$166.6KMTSFF
8$847,432$639,371.80$34,518$4,286.29+$812.9KMTSFF
9$6,063,003$5,156,250.22$43,912$6,494.35+$6.02MMTSFF
10$74,752,419$68,265,006.42$57,714$10,113.78+$74.69MMTSFF

MTSFF vs MRK: Complete Analysis 2026

MTSFFStock

Mitsui Fudosan Co., Ltd. operates as a real estate company in Japan. It operates through four segments: Leasing, Property Sales, Management, and Other. The Leasing segment leases office buildings and commercial facilities, and other properties. The Property Sales segment is involved in the sale of condominiums and detached housing to individuals; and rental housing and office buildings and other to investors. The Management segment engages in the property management and brokerage and asset management businesses. The Other segment engages in the housing construction and renovation business; and housing related material sales business. The company also offers car park leasing services; and operates hotels, golf courses, and resort facilities. In addition, it engages in the renewal work for offices and retail facilities; and electricity transmission and distribution and heat supply businesses, as well as operates as a retailer of flowers and ornamental plants, seeds, and other gardening products. The company was founded in 1941 and is headquartered in Tokyo, Japan.

Full MTSFF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this MTSFF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MTSFF vs SCHDMTSFF vs JEPIMTSFF vs OMTSFF vs KOMTSFF vs MAINMTSFF vs JNJMTSFF vs ABBVMTSFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.